Roche Acquires Telavant, Gains Rights to Innovative Antibody (RVT-3101) for Inflammatory Bowel Disease

Roivant (Nasdaq: ROIV) announced  the completion of the previously announced acquisition by Roche (SIX: RO, ROG; OTCQX: RHHBY) of Telavant, for an upf...

December 15, 2023 | Friday | News
Novozymes and Chr. Hansen Unveil Unified Identity: Novonesis, Marking a Powerful Synergy in the Biotech Industry

Novozymes and Chr. Hansen announced their future name ‘Novonesis’. The name reflects the beginning of an era of biosolutions where Novonesis wi...

December 13, 2023 | Wednesday | News
Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen

Expects to close Seagen acquisition on December 14, 2023 Announces changes in the commercial organization to incorporate Seagen and improve focus, speed...

December 12, 2023 | Tuesday | News
AstraZeneca to Acquire Icosavax, Including Promising Phase II RSV and hMPV Combination Vaccine

AstraZeneca has entered into a definitive agreement to acquire Icosavax, Inc. (NASDAQ: ICVX), a US-based clinical-stage biopharmaceutical company focused o...

December 12, 2023 | Tuesday | News
Flinn Scientific Expands Its Reach in Education Sector with Acquisition of Educational Innovations

This strategic move further solidifies Flinn Scientific's commitment to empowering science educators and advancing science education. Educational Innovati...

December 11, 2023 | Monday | News
Thermo Fisher Scientific Extends the Expiration of Tender Offer for All Outstanding Common Shares and ADSs of Olink

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, announced that its wholly owned subsidiary, O...

December 04, 2023 | Monday | News
Merck Acquires Caraway Therapeutics as Dementia Discovery Fund Facilitates Groundbreaking Move

The Dementia Discovery Fund (DDF), a SV Health Investors (SV) fund specialized in pursuing transformational therapeutic approaches for dementias including ...

November 23, 2023 | Thursday | News
Syncona to Acquire Freeline Therapeutics

Freeline shareholders to receive $6.50 per American Depositary Share, a 51% premium over closing price prior to announcement of Syncona’s initial pro...

November 23, 2023 | Thursday | News
Hovione Acquires ExtremoChem for Enhanced Biopharmaceutical Stabilization and Delivery

Hovione has acquired ExtremoChem Lda, a start-up company with a portfolio of rare sugars, synthetic analogues of the natural molecules found in extremoph...

November 21, 2023 | Tuesday | News
Hovione Acquires ExtremoChem for Biopharmaceutical Stabilization and Delivery

Hovione has acquired ExtremoChem Lda, a start-up company with a portfolio of rare sugars, synthetic analogues of the natural molecule...

November 17, 2023 | Friday | News
Inari Medical Closes Acquisition of LimFlow

“The close of the LimFlow acquisition allows us to begin to integrate this exciting technology that is offering new hope to patients suffering from C...

November 16, 2023 | Thursday | News
Lilly Announces Extension of Tender Offer to Acquire POINT Biopharma

The tender offer, which was previously scheduled to expire at one minute past 11:59 p.m., Eastern time, on Nov. 9, 2023, has been extended until 5:00 p.m.,...

November 09, 2023 | Thursday | News
Sharp acquires Berkshire Sterile Manufacturing

Sharp, a global leader in commercial pharmaceutical packaging and clinical trial supply services, has today announced the acquisition of Berkshire Ste...

October 19, 2023 | Thursday | News
Thermo Fisher Scientific to Acquire Olink, a Leader in Next-Generation Proteomics

Complements Existing Life Sciences and Mass Spectrometry Offerings, Accelerating Protein Biomarker Discovery and Providing Strong Synergy Opportuniti...

October 18, 2023 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close